Home Biosimilar Antibodies Immunology & Inflammation CD markers inhibitor -PD-1/PD-L1 antibody Volrustomig (Anti-CTLA4 & PD-1) For research use only.
Not for use in humans.

Volrustomig (Anti-CTLA4 & PD-1)

Synonyms: MEDI 5752

Volrustomig is an engineered fragment crystallizable (Fc) domain, monovalent bispecific IgG1 monoclonal antibody targeting PD-1 and CTLA-4, key immune checkpoint receptors. It enhances T-cell activation and antitumor immunity, making it a promising immunotherapy for various cancers. M.W 146.77 kDa

Volrustomig (Anti-CTLA4 & PD-1)

Purity & Quality Control

Choose Selective CD markers Inhibitors

Name Citation CD38 CD45 CD39 CD88 CD73 Others
RBN013209 0
MK-0159 0
CD38 inhibitor 1 (compound 78c) 5
AB680 0
NQ301 1 TXA2 receptor
SodiuM Metatungstate 3
PMX-53
LY-3475070
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Volrustomig is an engineered fragment crystallizable (Fc) domain, monovalent bispecific IgG1 monoclonal antibody targeting PD-1 and CTLA-4, key immune checkpoint receptors. It enhances T-cell activation and antitumor immunity, making it a promising immunotherapy for various cancers. M.W 146.77 kDa

Product Details

CAS No. N/A
Source CHO
Storage
(From the date of receipt)		 -80℃

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Volrustomig (Anti-CTLA4 & PD-1) | Volrustomig (Anti-CTLA4 & PD-1) supplier | purchase Volrustomig (Anti-CTLA4 & PD-1) | Volrustomig (Anti-CTLA4 & PD-1) cost | Volrustomig (Anti-CTLA4 & PD-1) manufacturer | order Volrustomig (Anti-CTLA4 & PD-1) | Volrustomig (Anti-CTLA4 & PD-1) distributor